Biocon gets 4 observations from USFDA for Andhra Pradesh facility

Biocon received four observations from the US health regulator after a GMP inspection at its API facility in Andhra Pradesh.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/GLMAsV2
via IFTTT